Alliance Pharma PLC has announced that Jeyan Heper, the Chief Operating Officer (COO), will be leaving the company on 31 August 2024. Heper joined the company in February 2023 and played a significant role in identifying growth opportunities in international consumer healthcare markets, particularly in China and the US. However, the company has decided to eliminate the COO role to streamline its management structure and accelerate its global expansion efforts.

Nick Sedgwick, the Chief Executive Officer of Alliance, expressed gratitude for Heper's contributions, stating, "I want to thank Jeyan for his contribution to Alliance, providing stability and valuable international consumer healthcare insights as we continue on our journey to transform to a high performing consumer healthcare company, built on a portfolio of leading, trusted and proven brands. We wish him well in his future endeavors."

Alliance Pharma PLC is an international healthcare group with a core focus on marketing Consumer Healthcare brands and a smaller Prescription Medicines business. The company holds marketing rights to approximately 80 brands, generating revenues from direct, distributor, and e-commerce sales. Headquartered in the UK, the Group employs around 290 people across Europe, North America, and the Asia Pacific region, with an asset-light approach by outsourcing manufacturing and logistics operations.

This update reflects Alliance Pharma's strategic decision to simplify its management structure and focus on global expansion, aiming to bring the consumer closer to the heart of the business. The company remains committed to its purpose of improving the lives of consumers and patients through the availability of clinically valuable healthcare products.